The latest developments, the hottest information, and the best content at your fingertips.

Blog

Back to Overview

Vitamin K1 Oil: From Pharmaceutical Staple to Cosmetic Innovator — A Procurement Perspective

Aug 19,2026

A comprehensive guide to Vitamin K1 oil — covering market trends, technical specifications, pharmaceutical and cosmetic applications, and procurement considerations.
Vitamin K1 Oil: From Pharmaceutical Staple to Cosmetic Innovator — A Procurement Perspective

I. Introduction: A Vitamin with Expanding Horizons

Vitamin K1 (Phylloquinone, Phytonadione) has long been recognized as an essential nutrient for blood coagulation. Its role as a cofactor for gamma-glutamyl carboxylase — activating coagulation factors II, VII, IX, and X — has made it a critical pharmaceutical ingredient for over half a century .

But the market is changing.

The global Vitamin K1 market was valued at approximately $109 million in 2025** and is projected to reach **$164 million by 2032, growing at a CAGR of 6.1% . This growth is being driven not just by traditional pharmaceutical applications, but by expanding use in dietary supplements, cosmetics, and infant nutrition.

For procurement professionals, this shift presents both opportunities and challenges. Understanding the technical specifications, market dynamics, and emerging applications of Vitamin K1 oil is essential for making informed sourcing decisions.

II. Physicochemical Properties: What Makes Vitamin K1 Unique

Chemical structure of Vitamin K1 (Phylloquinone) CAS 84-80-0

2.1 Key Characteristics

Vitamin K1 (CAS 84-80-0, molecular formula C₃₁H₄₆O₂) is a fat-soluble vitamin with distinct physicochemical properties :

Parameter Specification
Appearance Clear, intense yellow to yellow-green viscous oily liquid
Molecular Weight450.7 g/mo
Solubility Soluble in oils, ether, chloroform; practically insoluble in water
Storage 2–8°C, protected from light
Refractive IndexApproximately 1.526
Assay (Z+E isomers) 97.0% – 103.0%
Z-Isomer ≤ 21.0%

2.2 The Stability Challenge

Vitamin K1 is highly sensitive to light degradation. Patent data shows that unprotected Vitamin K1 can lose nearly 73% of its activity after 120 hours of light exposure, while stabilized formulations retain over 96% under the same conditions . This sensitivity makes proper formulation and packaging a critical quality consideration.

The addition of antioxidants like beta-carotene has been shown to significantly improve photostability — retaining 96.4% activity after 120 hours compared to 27.4% in control samples . This insight has direct implications for procurement: when sourcing Vitamin K1 oil, request stability data and verify that appropriate stabilizers are included in the formulation.

III. Market Landscape: Key Players and Applications

Global Vitamin K1 market size and growth forecast 2025-2032

3.1 Global Market Structure

The Vitamin K1 market is characterized by a concentrated supplier base, with key players including:

  • Nutrilo
  • DSM
  • BASF
  • Yongan Pharmaceutical
  • Shandong Guangtongbao Pharmaceuticals
  • Anhui Wanhe Pharmaceutical
  • Zhejiang Chengyi Pharmaceutical 

The market is segmented by grade (food grade, pharmaceutical grade) and application, with pharmaceutical-grade products commanding premium pricing due to stricter purity requirements .

3.2 Traditional Pharmaceutical Applications

Vitamin K1 applications across pharmaceutical cosmetic and supplement sectors

Vitamin K1's primary pharmaceutical applications include:

  • Treatment of Vitamin K deficiency bleeding — essential for liver synthesis of prothrombin
  • Neonatal prophylaxis — preventing hemorrhagic disease of the newborn
  • Management of anticoagulant-induced hypoprothrombinemia
  • Treatment of obstructive jaundice and biliary fistula 

3.3 Emerging Cosmetic Applications

Recent research has opened new markets for Vitamin K1 in topical formulations. Key developments include:

Topical Skin Therapy

A topical preparation containing 0.01-5% Vitamin K1, combined with transdermal enhancers (urea, menthol, and eucalyptus oil), has been developed to treat moderate to severe skin toxicity caused by EGFR-inhibitor anti-tumor drugs . This application addresses a significant unmet need in oncology supportive care.

Cosmetic Formulations

Vitamin K1 is increasingly incorporated into cosmetic formulations for its energizing and skin-conditioning properties. In vitro studies using human primary fibroblasts demonstrated that Vitamin K1 increases cellular energy levels, as measured by ATP content . Typical cosmetic formulations contain 0.1-1.0% Vitamin K1, often combined with UV filters in day creams and body lotions .

Nanoemulsion Technology

Advanced nanoemulsion formulations have been developed to enhance Vitamin K1 delivery. A stable nanoemulsion containing 0.2-1.0% Vitamin K1 with droplet sizes below 80 nm has been demonstrated, using phospholipid-to-vitamin K ratios of 15:1 to 25:1 . This technology significantly improves bioavailability and stability for both pharmaceutical and cosmetic applications.

IV. Regulatory Considerations

4.1 Quality Standards

Vitamin K1 is subject to strict quality standards:

  • USP (United States Pharmacopeia) — the primary reference standard for pharmaceutical grade
  • EP (European Pharmacopoeia)
  • FCC (Food Chemicals Codex) — for food-grade applications

Key quality parameters include assay (97.0-103.0%), Z-isomer content (≤21.0%), heavy metals, and related substances .

4.2 Labeling Claims

Products containing Vitamin K1 must comply with regional labeling requirements. In the US, Vitamin K1 is not listed in California Proposition 65, providing some regulatory relief .

V. Procurement Considerations

5.1 Key Sourcing Criteria

When sourcing Vitamin K1 oil, procurement professionals should prioritize:

Criterion Why It Matters
Assay (Z+E isomers) Must be 97.0-103.0%; indicates product purity
Z-Isomer Content ≤21.0%; higher levels may indicate degradation
Light Stability Data Confirms product will maintain potency during shelf life
Packaging Must protect from light (amber glass, opaque containers)
Storage Conditions 2-8°C, protected from light
Certifications USP, EP, or FCC compliance
COA DocumentationBatch-specific assay, impurities, and stability data

5.2 Supplier Evaluation

Evaluate suppliers based on:

  1. Production Capability — GMP-certified manufacturing facilities
  2. Quality Control — Comprehensive in-house testing (HPLC, heavy metals, microbial)
  3. Supply Reliability — Consistent batch-to-batch quality and on-time delivery
  4. Technical Support — Application guidance and formulation assistance

VI. Conclusion: A Market in Transition

The Vitamin K1 market is evolving beyond its traditional pharmaceutical base. Emerging applications in cosmetics, topical therapeutics, and advanced formulation technologies are creating new demand drivers. For procurement professionals, this means:

  1. Expanding application knowledge — understanding the technical requirements of different end-use sectors
  2. Prioritizing stability — requesting light stability data and ensuring appropriate packaging
  3. Verifying quality standards — confirming USP, EP, or FCC compliance for target applications
  4. Building supplier relationships — partnering with reliable manufacturers who can provide technical support

Get in Touch

If you have any questions, suggestions or want to collaborate, please fill in the form below to contact us. 

Submit Now